Strategic partnerships Koniku has established high-profile collaborations with Airbus and European aerospace partners to develop air-scanning and threat-detection systems, indicating a market validation path in defense and aerospace sectors. This suggests sales opportunities in integrated sensing, security solutions, and mission-critical hardware for aviation.

Bio as tech The company positions biological neurons as usable materials for real-world devices, signaling a unique value proposition for hardware manufacturers and systems integrators seeking biologically inspired intelligence components. Potential cross-sell in neuromorphic modules, sensors, and living-device integrations for advanced AI workloads.

Financial runway With funding of $49M and revenue under $1M, Koniku is in a growth phase with capital available for R&D partnerships, pilot programs, and co-development agreements. Focus sales on funded pilots, grant-enabled programs, and milestone-based collaborations to reduce client risk.

Tech-stack leverage Existing tooling and platforms such as MATLAB, AWS, Google Cloud, and LabVIEW indicate readiness for scalable prototyping and cloud-enabled data processing. Propose managed services, data analytics partnerships, and cloud-based deployment packages to accelerate time-to-value.

Specialized niche As a small team in biotech research, Koniku seeks to expand within neurotechnology devices and brain-machine interfaces. Target opportunities include aerospace safety systems, early-warning biosurveillance, and next-gen electronic noses, aligning with potential defense, aviation, and security customers seeking innovation partnerships.